TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07610395: Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Sponsor: Altesa Biosciences, Inc. · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 180 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,263,800

Rescue Site Savings

+$1,499,400

Unlock Full NCT07610395 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07610395 Rescue Dossier →